Related references
Note: Only part of the references are listed.Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10
Jing Yang et al.
CANCER LETTERS (2023)
Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms
Irene Kleinberger et al.
BMC CANCER (2022)
ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors
Naosuke Hoshina et al.
JOURNAL OF NEUROSCIENCE (2022)
PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer
Tzu-Ming Jao et al.
CANCER LETTERS (2021)
Age- and sex-specific fear conditioning deficits in mice lacking Pcdh10, an Autism Associated Gene
Sarah L. Ferri et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2021)
Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins
Mingfei Xu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR-576-5p/PCDH10 axis
Jiahui Zhou et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer
Maria Dobre et al.
FRONTIERS IN ONCOLOGY (2021)
FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes
Xiao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
HOTAIR Induces Methylation of PCDH10, a Tumor Suppressor Gene, by Regulating DNMT1 and Sponging with miR-148b in Gastric Adenocarcinoma
Seung In Seo et al.
YONSEI MEDICAL JOURNAL (2021)
Protocadherins at the Crossroad of Signaling Pathways
Anna Pancho et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
An epigenome-wide association study of early-onset major depression in monozygotic twins
Roxann Roberson-Nay et al.
TRANSLATIONAL PSYCHIATRY (2020)
The role of clustered protocadherins in neurodevelopment and neuropsychiatric diseases
Erin Flaherty et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2020)
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
Maria Cristina Curia et al.
BMC CANCER (2019)
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
Francesco Caputo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 4: Evidence from chromosome 4 high-density association screen
Jian Tang et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2019)
Deletions in metastatic colorectal cancer with chromothripsis
E. Skuja et al.
Experimental Oncology (2019)
Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
Yuntao Bing et al.
MEDICINE (2018)
Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
Wentao Liu et al.
ONCOLOGY LETTERS (2018)
Protocadherin 10 alters γ oscillations, amino acid levels, and their coupling; baclofen partially restores these oscillatory deficits
Russell G. Port et al.
NEUROBIOLOGY OF DISEASE (2017)
Synaptic Plasticity, Engrams, and Network Oscillations in Amygdala Circuits for Storage and Retrieval of Emotional Memories
Marco Bocchio et al.
NEURON (2017)
PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells
Mingxin Ye et al.
ONCOLOGY REPORTS (2017)
δ-Protocadherins: Organizers of neural circuit assembly
Sarah E. W. Light et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Aberrant gene-specific DNA methylation signature analysis in cervical cancer
Samatha Bhat et al.
TUMOR BIOLOGY (2017)
Epigenetic silencing of protocadherin 10 in colorectal cancer
Xian Zhong et al.
ONCOLOGY LETTERS (2017)
Sociability Deficits and Altered Amygdala Circuits in Mice Lacking Pcdh10, an Autism Associated Gene
Hannah Schoch et al.
BIOLOGICAL PSYCHIATRY (2017)
Whole-genome association analysis of treatment response in obsessive-compulsive disorder
H. Qin et al.
MOLECULAR PSYCHIATRY (2016)
Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy
Nadia P. Goncalves et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma
Yihua Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells
Chan Qiu et al.
ONCOLOGY REPORTS (2016)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
Ying Qi et al.
ONCOTARGET (2016)
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
Qiu-Kui Deng et al.
MEDICAL SCIENCE MONITOR (2016)
Aberrant methylation of PCDH10 and RASSFIA genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer
Charinya Pimson et al.
PEERJ (2016)
Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer
Ya-Chao Hou et al.
CANCER BIOMARKERS (2015)
DNA Methylation Predicts Progression of Human Gastric Lesions
Barbara G. Schneider et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
PCDH10 Interacts With hTERT and Negatively Regulates Telomerase Activity
Li-Na Zhou et al.
MEDICINE (2015)
PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway
Yonghui Xu et al.
ONCOLOGY REPORTS (2015)
Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer
Hiroaki Harada et al.
CANCER MEDICINE (2015)
PCDH10 is required for the tumorigenicity of glioblastoma cells
Kanae Echizen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
A Novel Wnt Regulatory Axis in Endometrioid Endometrial Cancer
Yu Zhao et al.
CANCER RESEARCH (2014)
Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis
Tzu-Ming Jao et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Clinical Significance of the Methylated Cytosine-Phosphate-Guanine Sites of Protocadherin-10 Promoter for Evaluating the Prognosis of Gastric Cancer
Jingyu Deng et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer et al.
MODERN PATHOLOGY (2014)
Nuclear factor-κB is involved in the protocadherin-10-mediated pro-apoptotic effect in multiple myeloma
Zhen Li et al.
MOLECULAR MEDICINE REPORTS (2014)
De novo mutations in schizophrenia implicate synaptic networks
Menachem Fromer et al.
NATURE (2014)
Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
Wen-Ping Li
MEDICAL SCIENCE MONITOR (2014)
Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer
E. Danese et al.
BRITISH JOURNAL OF CANCER (2013)
Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression
Song Fang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2013)
PCDH10 Promoter Hypermethylation is Frequent in most Histologic Subtypes of Mature Lymphoid Malignancies and Occurs Early in Lymphomagenesis
Gopeshwar Narayan et al.
GENES CHROMOSOMES & CANCER (2013)
Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
Xian Zhong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
The Clinical Significance of PCDH10 Promoter Methylation in Patients with Bladder Transitional Cell Carcinoma
Ying-Li Lin et al.
UROLOGIA INTERNATIONALIS (2013)
DNA methylation as an epigenetic biomarker in colorectal cancer
Tiago Donizetti Silva et al.
ONCOLOGY LETTERS (2013)
Role of PCDH10 and its hypermethylation in human gastric cancer
Zesong Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer
Xiaokui Tang et al.
CANCER BIOMARKERS (2012)
Multiple Autism-Linked Genes Mediate Synapse Elimination via Proteasomal Degradation of a Synaptic Scaffold PSD-95
Nien-Pei Tsai et al.
CELL (2012)
Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma
Ying Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer
Y. L. Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results
Cuei Jyuan Lin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Epigenetic inactivation of PCDH10 in human prostate cancer cell lines
Zesong Li et al.
CELL BIOLOGY INTERNATIONAL (2011)
PCDH10 is a candidate tumour suppressor gene in medulloblastoma
Kelsey C. Bertrand et al.
CHILDS NERVOUS SYSTEM (2011)
Delta protocadherin 10 is regulated by activity in the mouse main olfactory system
Eric O. Williams et al.
FRONTIERS IN NEURAL CIRCUITS (2011)
Non-clustered protocadherin
Soo-Young Kim et al.
CELL ADHESION & MIGRATION (2011)
Novel Application of Structural Equation Modeling to Correlation Structure Analysis of CpG Island Methylation in Colorectal Cancer
Noriko Tanaka et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers
B. Yu et al.
NEOPLASMA (2010)
Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings
Kai-Hung Wang et al.
CANCER SCIENCE (2009)
Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl(+) leukemic cells
Kefeng Ding et al.
CARCINOGENESIS (2009)
Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer
Jun Yu et al.
GASTROENTEROLOGY (2009)
Protocadherin PCDH10, Involved in Tumor Progression, Is a Frequent and Early Target of Promoter Hypermethylation in Cervical Cancer
Gopeshwar Narayan et al.
GENES CHROMOSOMES & CANCER (2009)
Genome-Wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes
Maja Bucan et al.
PLOS GENETICS (2009)
Contact-dependent promotion of cell migration by the OL-protocadherin-Nap1 interaction
Shinsuke Nakao et al.
JOURNAL OF CELL BIOLOGY (2008)
Identifying autism loci and genes by tracing recent shared ancestry
Eric M. Morrow et al.
SCIENCE (2008)
OL-protocadherin is essential for growth of striatal axons and thalamocortical projections
Masato Uemura et al.
NATURE NEUROSCIENCE (2007)
Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain
S.-Y. Kim et al.
NEUROSCIENCE (2007)
Cadherins in development: cell adhesion, sorting, and tissue morphogenesis
Jennifer M. Halbleib et al.
GENES & DEVELOPMENT (2006)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
Distribution of OL-protocadherin protein in correlation with specific neural compartments and local circuits in the postnatal mouse brain
E Aoki et al.
NEUROSCIENCE (2003)
Disabled-1 interacts with a novel developmentally regulated protocadherin
R Homayouni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification and characterization of three members of a novel subclass of protocadherins
T Wolverton et al.
GENOMICS (2001)